home / stock / cntx / cntx quote
Last: | $1.4101 |
---|---|
Change Percent: | -2.9% |
Open: | $1.42 |
Close: | $1.4101 |
High: | $1.4498 |
Low: | $1.37 |
Volume: | 19,984 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.4101 | $1.42 | $1.4101 | $1.4498 | $1.37 | 19,984 | 04-26-2024 |
$1.38 | $1.32 | $1.38 | $1.38 | $1.32 | 27,931 | 04-25-2024 |
$1.3 | $1.39 | $1.3 | $1.44 | $1.3 | 36,608 | 04-24-2024 |
$1.41 | $1.4499 | $1.41 | $1.48 | $1.38 | 23,977 | 04-23-2024 |
$1.36 | $1.3 | $1.36 | $1.4 | $1.3 | 13,917 | 04-22-2024 |
$1.32 | $1.38 | $1.32 | $1.45 | $1.32 | 5,702 | 04-19-2024 |
$1.41 | $1.44 | $1.41 | $1.5 | $1.37 | 45,929 | 04-18-2024 |
$1.39 | $1.475 | $1.39 | $1.5242 | $1.365 | 34,077 | 04-17-2024 |
$1.46 | $1.465 | $1.46 | $1.5799 | $1.4312 | 36,225 | 04-16-2024 |
$1.5 | $1.45 | $1.5 | $1.58 | $1.45 | 34,979 | 04-15-2024 |
$1.49 | $1.48 | $1.49 | $1.58 | $1.4151 | 115,081 | 04-12-2024 |
$1.52 | $1.37 | $1.52 | $1.6 | $1.34 | 179,421 | 04-11-2024 |
$1.35 | $1.35 | $1.35 | $1.3822 | $1.3002 | 42,542 | 04-10-2024 |
$1.31 | $1.28 | $1.31 | $1.34 | $1.27 | 26,466 | 04-09-2024 |
$1.3 | $1.37 | $1.3 | $1.47 | $1.28 | 35,358 | 04-08-2024 |
$1.27 | $1.28 | $1.27 | $1.36 | $1.26 | 9,929 | 04-05-2024 |
$1.28 | $1.24 | $1.28 | $1.3 | $1.23 | 12,914 | 04-04-2024 |
$1.24 | $1.33 | $1.24 | $1.4 | $1.24 | 61,775 | 04-03-2024 |
$1.36 | $1.38 | $1.36 | $1.4 | $1.3 | 61,235 | 04-02-2024 |
$1.37 | $1.5 | $1.37 | $1.57 | $1.3125 | 488,239 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Context Therapeutics Inc. Company Name:
CNTX Stock Symbol:
NASDAQ Market:
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational Ne...
CTIM-76 IND filing on track for late March 2024 Cash and cash equivalents of $14.4 million as of December 31, 2023 Company expects its cash and cash equivalents will continue to fund operations into late 2024 PHILADELPHIA, March 21, 2024 (GLOBE NEWSWIRE) -- Context Therape...
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter finan...